Rapamycin is neuroprotective in a rat chronic hypertensive glaucoma model.
Glaucoma is a leading cause of irreversible blindness. Injury of retinal ganglion cells (RGCs) accounts for visual impairment of glaucoma. Here, we report rapamycin protects RGCs from death in experimental glaucoma model and the underlying mechanisms. Our results showed that treatment with rapamycin...
Main Authors: | Wenru Su, Zuohong Li, Yu Jia, Yehong Zhuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4055719?pdf=render |
Similar Items
-
Correction: Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model.
by: Wenru Su, et al.
Published: (2019-01-01) -
Clinical Outcomes of FP-7/8 Ahmed Glaucoma Valves in the Management of Refractory Glaucoma in the Mainland Chinese Population.
by: Yingting Zhu, et al.
Published: (2015-01-01) -
CircXPO5 Plays a Neuroprotective Function in the Lateral Geniculate Nucleus of Glaucoma by Regulating GRIN2A
by: Zhichao Yan, et al.
Published: (2022-06-01) -
Neuroprotective effects of bis(7)-tacrine in rat model with glaucoma
by: Jia-Hua Fang, et al.
Published: (2020-06-01) -
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
by: Mi-Lyang Kim, et al.
Published: (2021-11-01)